The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / November / The Bone-Eye Connection
Retina Research & Innovations News

The Bone–Eye Connection

Multi-cohort study links lower bone mineral density with greater AMD risk

11/3/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll
Objective:

To investigate whether bone mineral density (BMD) is associated with age-related macular degeneration (AMD) and to explore possible causal, molecular, and experimental links.

Approach:
  • Human cohorts: Analyzed UK Biobank (275,752 participants), NHANES (3,425), and a Tianjin hospital cohort (1,000), comparing BMD and AMD status.
  • Additional analyses: Used machine learning, Mendelian randomization, proteomic and metabolomic profiling, and a glucocorticoid-induced low-BMD rat model.
Key Findings:
  • Across all three cohorts, participants with AMD were older and had lower BMD than those without AMD.
  • Higher BMD was associated with lower AMD incidence in UK Biobank (adjusted hazard ratio 0.89); inverse associations were also observed in NHANES and Tianjin.
  • Age and BMD were repeatedly important features in machine-learning models, but the added predictive value of BMD remains uncertain and the models lack external validation.
  • Mendelian randomization results were consistent with a modest contribution of higher BMD to lower AMD risk, with no strong evidence of reverse causality.
  • GZMA, NELL1, and COL2A1 were identified as potential molecular intermediates; analyses also implicated extracellular matrix remodeling, lipid transport, amino acid metabolism, and inflammation.
  • Low-BMD rats showed outer retinal thinning, narrower retinal vessels, and delayed visual-spatial performance, but did not develop hallmark features of human AMD.
Interpretation:

The authors describe BMD as a possible marker of systemic biological aging associated with retinal vulnerability, rather than an established standalone AMD biomarker.

Limitations:
  • AMD ascertainment and BMD measurement differed between cohorts.
  • Residual confounding may remain.
  • Predictive analyses were exploratory, conducted separately in heterogeneous cohorts, and not externally validated.
  • The animal model did not reproduce hallmark features of human AMD.
Conclusion:

The findings support further investigation of a possible bone–eye association, but the authors characterize it as a hypothesis requiring caution.

Sources:
  • Article context provided by the user

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: